Peter Feinberg - 22 Mar 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Issuer symbol
IMRX
Transactions as of
22 Mar 2024
Net transactions value
+$63,712
Form type
4
Filing time
25 Mar 2024, 09:13:49 UTC
Previous filing
19 Mar 2024
Next filing
10 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Purchase $63,712 +25,000 +29% $2.55 111,766 22 Mar 2024 Direct F1
holding IMRX Class A Common Stock 392,242 22 Mar 2024 General Partner of PF Associates L.P.
holding IMRX Class A Common Stock 476,615 22 Mar 2024 General Partner of PEF LLC.
holding IMRX Class A Common Stock 115,441 22 Mar 2024 General Partner of S4K Investments LLC.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.52 to $2.57. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.